Pharmacytimes: Condition Center: HIV http://www.pharmacytimes.com/condition-resources/hiv/condition-rss HIV en-us Thu, 24 May 2018 12:26:47 UTC Thu, 24 May 2018 12:26:47 UTC Juluca for HIV: What Pharmacists Should Know http://www.pharmacytimes.com/contributor/timothy-o-shea/2018/05/juluca-for-hiv-what-pharmacists-should-know This article highlights several key therapeutics areas with the prescription medication. 10:45 AM, Tue May 15, 2018 Researchers and Clinicians Confront Today's HIV Profile http://www.pharmacytimes.com/resource-centers/hiv/researchers-and-clinicians-confront-todays-hiv-profile- The Conference on Retroviruses and Opportunistic Infections (CROI) annually assembles researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS, and related infectious diseases. 1:45 PM, Wed May 9, 2018 Syringe Sales Without a Prescription: What Pharmacists Think http://www.pharmacytimes.com/resource-centers/hiv/syringe-sales-without-a-prescription-what-pharmacists-think Legalizing the sale of syringes creates accessible, affordable, and reliable sources of sterile syringes for injection drug users (IDU). 5:38 PM, Tue April 24, 2018 Falling Sodium Levels in HIV: Watch the Velocity of the Change http://www.pharmacytimes.com/resource-centers/hiv/falling-sodium-levels-in-hiv-watch-the-velocity-of-the-change- Velocity of change is key when it comes to falling sodium levels. Hyponatremia is the most common electrolyte disorder seen in hospitals. 12:34 PM, Tue April 17, 2018 Menopause and HIV: Data Gap, Limited Care http://www.pharmacytimes.com/resource-centers/hiv/menopause-and-hiv-data-gap-limited-care Advancing therapies have resulted in more women living with HIV who experience menopause. Unfortunately, many WLHIV fall into a knowledge gap. 12:46 PM, Mon April 9, 2018 Ibalizumab-uiyk for HIV: What Pharmacists Should Know http://www.pharmacytimes.com/contributor/timothy-o-shea/2018/03/ibalizumabuiyk-for-hiv-what-pharmacists-should-know This article highlights several key therapeutics areas with&nbsp;ibalizumab-uiyk that every pharmacist should know. 9:00 AM, Sun March 25, 2018 HIV and Neurology: An Overview of Complications and Challenges http://www.pharmacytimes.com/resource-centers/hiv/hiv-and-neurology-an-overview-of-complications-and-challenges A continuing concern is HIV-associated neurologic syndromes. 8:48 AM, Thu March 22, 2018 Lightening the Load: Looking for a Cure for HIV http://www.pharmacytimes.com/resource-centers/hiv/lightening-the-load-looking-for-a-cure-for-hiv HIV is a wide-reaching public health problem, with more than 37 million individuals infected worldwide. Current antiretroviral therapy has a varying array of uses, ranging from HIV treatment to pre-exposure prophylaxis. 11:00 AM, Fri March 16, 2018 HIV and Neurocognitive Disorders: Looking for Drugs that Decrease Inflammation http://www.pharmacytimes.com/resource-centers/hiv/hiv-and-neurocognitive-disorders-looking-for-drugs-that-decrease-inflammation Up to half of people living with HIV experience HIV-associated neurocognitive disorders, a neurological manifestation of HIV-1 infection. 8:00 AM, Mon March 12, 2018 FDA Approves Treatment for Patients with Multi-Drug Resistant HIV http://www.pharmacytimes.com/resource-centers/hiv/fda-approves-treatment-for-patients-with-multidrug-resistant-hiv Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.&nbsp; 2:49 PM, Tue March 6, 2018 HIV Prophylaxis with PrEP: Less May be More http://www.pharmacytimes.com/resource-centers/hiv/Hiv-prophylaxis-with-prep-less-may-be-more-Blerina-mukallari Pre-exposure prophylaxis saves lives by reducing the risk of acquiring HIV, but the need for cost-saving is great. 1:02 PM, Thu March 1, 2018 Guidelines Discuss Treatment Options for Patients with HIV, Cancer http://www.pharmacytimes.com/resource-centers/hiv/guidelines-discuss-treatment-options-for-patients-with-hiv-cancer 1:16 PM, Tue February 27, 2018 FDA: Antibiotic Commonly Taken by Patients with HIV May Increase CV Risk http://www.pharmacytimes.com/resource-centers/cardiovascular-health/fda-antibiotic-commonly-taken-by-patients-with-hiv-may-increase-cv-risk Clarithromycin (Biaxin) may increase the risk of heart problems and death among patients with cardiovascular disease.<br /> &nbsp; 4:52 PM, Thu February 22, 2018 FDA Tentatively OKs Fixed-Dose HIV Combo Therapy http://www.pharmacytimes.com/product-news/fda-tentatively-oks-fixeddose-hiv-combo-therapy Under the PEPFAR program, the antiretroviral (ARV) combination will be available in developing countries as a treatment for patients with HIV/AIDS. 2:58 AM, Wed February 21, 2018 Opioids May Boost Pneumococcal Infection Risk http://www.pharmacytimes.com/contributor/marilyn-bulloch-pharmd-bcps/2018/02/opioids-may-boost-pneumococcal-infection-risk A new study published in the Annals of Internal Medicine this week suggests that opioids may pose a different, unintended untoward consequence in patients: an increased risk of pneumococcal infection. 8:57 PM, Thu February 15, 2018 Pursuing Credentialing in HIV: Why? Why Not? http://www.pharmacytimes.com/resource-centers/hiv/pursuing-credentialing-in-hiv-why-why-not As the job market for pharmacists becomes more competitive, many pharmacists are turning to credentialing as a way to distinguish themselves professionally.<br /> &nbsp; 1:17 PM, Wed February 14, 2018 Pharmacist-Administered ART Adherence Clinic Makes Inroads http://www.pharmacytimes.com/resource-centers/hiv/pharmacistadministered-art-adherence-clinic-makes-inroads According to the US Department of Health and Human services, only 57% of people who receive an HIV diagnosis stay in HIV care.<br /> &nbsp; 3:40 PM, Thu February 8, 2018 FDA OKs 2 Fixed Dose HIV Treatments http://www.pharmacytimes.com/product-news/fda-oks-2-fixed-dose-hiv-treatments Officials with the FDA have approved 2 different fixed dose drugs indicated to treat HIV-1: Symfi Lo tablets&nbsp;and Biktarvy. 9:14 AM, Thu February 8, 2018 FDA Updates HIV Drug Label to Include Dosing for Pregnant Patients http://www.pharmacytimes.com/product-news/fda-updates-hiv-drug-label-to-include-dosing-for-pregnant-patients The FDA updated the labeling for rilipivirine (Edurant) for the treatment of HIV-positive pregnant patients who were on stable treatment prior to conception and who are virologically suppressed.&nbsp; 12:30 PM, Sat February 3, 2018 Dual Eligibility: Did Medication Reimbursement Changes Affect Adherence? http://www.pharmacytimes.com/resource-centers/hiv/dual-eligibility-did-medication-reimbursement-changes-affect-adherence The researchers concluded that this information has implications for all privatized, market-based prescription drug plans. 1:00 PM, Thu January 18, 2018